| Literature DB >> 19360087 |
Joachim Scholz1, Richard J Mannion, Daniela E Hord, Robert S Griffin, Bhupendra Rawal, Hui Zheng, Daniel Scoffings, Amanda Phillips, Jianli Guo, Rodney J C Laing, Salahadin Abdi, Isabelle Decosterd, Clifford J Woolf.
Abstract
BACKGROUND: Adequate pain assessment is critical for evaluating the efficacy of analgesic treatment in clinical practice and during the development of new therapies. Yet the currently used scores of global pain intensity fail to reflect the diversity of pain manifestations and the complexity of underlying biological mechanisms. We have developed a tool for a standardized assessment of pain-related symptoms and signs that differentiates pain phenotypes independent of etiology. METHODS ANDEntities:
Mesh:
Year: 2009 PMID: 19360087 PMCID: PMC2661253 DOI: 10.1371/journal.pmed.1000047
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Figure 1Standards for the Reporting of Diagnostic Accuracy (STARD) flowchart for the validation of StEP (Part 2 of the study).
Patient characteristics.
| Characteristic | Study Part 1: Development of StEP | Study Part 2: Validation | |||||
| DN | PHN | Radicular LBP | Neuropathic Pain (Total) | Axial LBP | Radicular LBP | Axial LBP | |
| Total number | 50 | 23 | 57 | 130 | 57 | 75 | 62 |
| Age, median (range), y | 55 (38–71) | 67 (45–92) | 50 (20–85) | 55 (20–92) | 46 (19–77) | 45 (20–82) | 55 (24–78) |
| Women | 27 (54) | 11 (48) | 28 (49) | 66 (51) | 35 (61) | 41 (55) | 35 (56) |
| Men | 23 (46) | 12 (52) | 29 (51) | 64 (49) | 22 (39) | 34 (45) | 27 (44) |
| Pain duration, y, median (range) | 4 (0.42–15) | 2 (0.25–34) | 4 (0.33–29) | 4 (0.25–34) | 5 (0.33–39) | 1 (0.25–34) | 5 (0.33–46) |
| Global pain intensity, NRS, median (range) | 5 (0–10) | 4 (0–10) | 5 (0–10) | 5 (0–10) | 5 (0–8) | 8 (6–10) | 7 (6–10) |
| Analgesic treatment (drugs) | |||||||
| Antidepressants | 4 (8) | 5 (22) | 7 (12) | 16 (12) | 4 (7) | 11 (15) | 13 (21) |
| Anticonvulsants | 16 (32) | 8 (35) | 14 (25) | 38 (29) | 9 (16) | 10 (13) | 5 (8) |
| NSAIDs, acetaminophen | 28 (56) | 10 (43) | 39 (68) | 77 (59) | 47 (82) | 54 (72) | 49 (79) |
| Muscle relaxants | 1 (2) | 0 (0) | 16 (28) | 17 (13) | 11 (19) | 1 (1) | 0 (0) |
| Benzodiazepines | 0 (0) | 0 (0) | 4 (7) | 4 (3) | 4 (7) | 6 (8) | 4 (6) |
| Opioids | 12 (24) | 8 (35) | 28 (49) | 48 (37) | 26 (46) | 45 (60) | 41 (66) |
| Local anesthetics | 0 (0) | 6 (26) | 2 (4) | 8 (6) | 4 (7) | 1 (1) | 1 (2) |
| Glucocorticoids | 1 (2) | 1 (4) | 15 (26) | 17 (13) | 10 (18) | 3 (4) | 2 (3) |
| Other | 0 (0) | 0 (0) | 2 (4) | 2(2) | 1 (2) | 1 (1) | 4 (6) |
| Analgesic treatment (other) | |||||||
| Physical therapy | 7 (14) | 1 (4) | 32 (56) | 40 (31) | 27 (47) | 7 (9) | 12 (19) |
| TENS, SCS | 1 (2) | 0 (0) | 5 (9) | 6 (5) | 2 (4) | 3 (4) | 7 (11) |
| Chiropractic | 0 (0) | 1 (4) | 11 (19) | 12 (9) | 6 (11) | 0 (0) | 0 (0) |
| Acupuncture | 7 (14) | 4 (17) | 6 (11) | 17 (13) | 6 (11) | 1 (1) | 0 (0) |
| Other | 1 (2) | 0 (0) | 4 (7) | 5 (4) | 1 (2) | 1 (1) | 3 (5) |
| No treatment | 9 (18) | 2 (9) | 2 (4) | 13 (10) | 2 (4) | 8 (11) | 2 (3) |
Data are presented as number (%) unless otherwise indicated.
As reported on the day of the assessment, prior to the examination. Some patients with predominantly intermittent pain episodes were free of pain at this time (NRS = 0).
Topical application or injection.
Mexiletine (1), zopiclone (1), glucosamine (1), quinine (1), and botulinum toxin injections (3).
Lumbar support (2), muscle relaxation (1), massage (1), meditation (2), yoga (2), hypnosis (1), and magnets (1).
NRS, numerical rating scale; NSAIDs, nonsteroidal anti-inflammatory drugs; SCS, spinal cord stimulation; TENS, transcutaneous electrical nerve stimulation.
Figure 2Hierarchical cluster analysis of patient subgroups defined by constellations of pain-related symptoms and signs.
(A) Individual patients are symbolized by short vertical lines at the bottom of the dendrogram. Horizontal lines indicate similarities between the patients' pain, whereas upper vertical lines represent differences between pain-related signs or symptoms. At the indicated separation threshold (arrow), we identified eight subgroups of patients (clusters C1 to C8) with distinct constellations of pain-related symptoms and signs (pain subtypes). (B) Patients with DN, PHN, and radicular LBP were distributed across the clusters C1 to C6, whereas patients with axial LBP almost exclusively formed the clusters C7 and C8.
Figure 3Association patterns of pain-related symptoms and signs.
Circles indicate the presence of symptoms and signs, with empty circles denoting a sensory deficit. The diameter of the circles reflects the relative frequency of each symptom or sign in a patient cluster independent of the intensity of pain associated with the symptom or sign, or the severity of sensory loss. Closely related items are grouped, for example the responses to stimulation with the von Frey filaments of 2.0-g and 26.0-g strength.
Figure 4Physical examination, rather than symptom exploration, is crucial for the differentiation between patient subgroups.
(A) A hierarchical cluster analysis based solely on the results of physical tests. (B) The same analysis including only pain-related symptoms reported in the interview.
Figure 5Identification of discriminatory pain assessment items.
(A) Using a classification tree analysis, we determined symptoms and signs that characterized the pain in patients with DN, PHN, radicular LBP, and axial LBP. We identified an abnormal response to pinprick (either decreased response or hyperalgesia) as the best indicator of neuropathic pain. Abnormal responses to cold or warm stimuli and to blunt pressure further supported the distinction between neuropathic pain and non-neuropathic (axial) LBP. Among patients with neuropathic pain, a positive straight-leg-raising sign was closely associated with radicular LBP, and a deficit in the detection of vibration was the best marker of DN. aLBP, axial low back pain; rLBP, radicular low back pain. (B) In a separate analysis, we identified those pain assessment items that contributed to the differentiation of pain subtypes. Responses to physical tests dominated among the key characteristics of pain subtypes responsible for the allocation of patients into clusters C1 to C8. Pain assessment items in (A) and (B) are listed according to their contribution to the differentiation of painful conditions and pain subtypes, respectively. The most discriminatory items are shown on top and in bold font.
StEP scores for the distinction between radicular and axial LBP.
| StEP Variable | Score |
| Radicular pain in the straight-leg-raising test | 7 |
| Abnormal response to cold temperature (decrease or allodynia) | 3 |
| Abnormal response to pinprick (decrease or hyperalgesia) | 2 |
| Abnormal response to blunt pressure (decrease or evoked pain) | 1 |
| Decreased response to vibration | 1 |
| Dysesthesia (any) | 1 |
| Temporal summation | −1 |
| Burning or cold quality of the pain | −1 |
| Abnormal response to brush movement (decrease or allodynia) | −2 |
| Ongoing pain | −2 |
| Skin changes (any) | −3 |
Scores reflect the regression coefficients of grouped StEP items; for example, a score of 2 was given when the response to pinprick was decreased or when pinprick evoked a hyperalgesic response. StEP items with a regression coefficient of 0 (zero) are not listed. A higher score is indicative of radicular LBP (see Table 3).
Accuracy of StEP in identifying patients with radicular LBP at different cutoff values of the total score.
| StEP Cutoff Score | Sensitivity | Specificity | Correctly Diagnosed Patients | Positive Predictive Value | Negative Predictive Value |
| 6 | 81 (71–89) | 100 (94–100) | 123 (90) | 100 (94–100) | 82 (71–90) |
| 5 | 88 (78–94) | 97 (89–100) | 126 (92) | 97 (90–100) | 87 (77–94) |
| 4 | 92 (83–97) | 97 (89–100) | 129 (94) | 97 (90–100) | 91 (81–97) |
| 3 | 93 (85–98) | 94 (84–98) | 128 (93) | 95 (87–99) | 92 (82–97) |
| 2 | 96 (89–99) | 82 (70–91) | 123 (90) | 87 (78–93) | 94 (85–99) |
| 1 | 97 (91–100) | 69 (56–80) | 116 (85) | 79 (70–87) | 96 (85–99) |
| 0 | 99 (93–100) | 52 (39–65) | 106 (77) | 71 (61–80) | 97 (84–100) |
Correctly diagnosed patients are given as number (%). All other values represent % (95% CI).
Figure 6ROC curves for the distinction between radicular and axial LBP based on StEP.
Diagnostic accuracy of StEP for the identification of radicular LBP compared to the DN4 screening tool for neuropathic pain and spinal MRI.
| Measure of Accuracy | StEP (All Patients) | DN4, Ten Items | DN4, Seven Items | StEP (Patients with MRI) | Spinal MRI |
| AUC, mean±standard error | 0.98±0.01 | 0.71±0.04 | 0.67±0.05 | 0.97±0.02 | 0.69±0.07 |
| Sensitivity | 92 (83–97) | 61 (49–72) | 68 (56–78) | 90 (79–97) | 86 (74–94) |
| Specificity | 97 (89–100) | 73 (60–83) | 56 (43–69) | 95 (77–100) | 41 (21–64) |
| Correctly diagnosed patients, number (%) | 129 (94) | 91 (66) | 86 (63) | 67 (92) | 53 (73) |
| Positive predictive value | 97 (90–100) | 73 (60–83) | 65 (54–76) | 98 (89–100) | 77 (64–87) |
| Negative predictive value | 91 (81–97) | 61 (49–72) | 59 (46–72) | 81 (61–93) | 56 (30–80) |
Values represent % (95% CI) unless otherwise noted.
Using deviation of a nerve root caused by disk herniation and moderate stenosis (≥2/3) of the spinal canal or a lateral recess as cutoff values.
p<0.001, when compared to the area under the ROC curve for StEP.
The spinal MR images of 73 patients were analyzed.
Figure 7Association patterns of symptoms and signs in patients with chronic LBP in Part 2 of the study.
Subgroups of patients with radicular and axial LBP were identified based on those symptoms and signs that characterized the patient clusters C4, C6, C7, and C8 in Part 1 of the study (compare Figure 5B).